Ireland· IE-PA-PA0281/026/007
Primacine 125 mg/5 ml Granules for Oral Suspension
A erythromycin product containing erythromycin ethylsuccinate, registered in Ireland by Pinewood Laboratories Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Erythromycin is registered in 13 of 19 countries.
Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Erythromycin · ATC J01FA01
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Erythromycin ethylsuccinate
- Manufacturer
- Pinewood Laboratories Ltd
- Country
- Ireland (IE)
- ATC code
- J01FA01
- ATC class
- Erythromycin
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0281/026/007
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1011 interactions on record for erythromycin.
Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erythromycin · interactions on record
1011 records
- 216 severe
- 424 moderate
- 70 minor
- 227 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
74 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erythromycin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomErythromycin ethyl succinate 125mg/5ml oral suspensionKent Pharma (UK) Ltd
- United StatesE.E.SCarnegie Pharmaceuticals LLC
- FinlandAbboticinAbbott Scandinavia AB
- BelgiumErythrocine 250 mg/5 mlAmdipharm
- GermanyErythrocin NeoAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Erythroforte
- Germany · Erythrocin Neo
- Denmark · Abboticin, Abboticin Novum
- Spain · Eritromicina Normon, Pantomicina
- France · Ery Enfants, Erythrocine
- United Kingdom (Northern Ireland) · Erythromycin, Erythromycin Amdipharm Uk
- Luxembourg · Erythrocine, Erythroforte
- Malta · Primacine
- Norway · Abboticin Es
- Portugal · E.S.E. 500, Eritrocina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfdc4627-b565-4484-81ce-71ca977bdf3e GET /v1/drugs/bfdc4627-b565-4484-81ce-71ca977bdf3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granules for oral suspension",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J01FA",
"J01FA01"
],
"strength": null,
"pa_number": "PA0281/026/007",
"substances": [
"Erythromycin ethylsuccinate"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "13/11/1998",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about erythromycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.